1-6 of 6
Daniel Sullivan, MD MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1/2 Study of the Second Generation Selective Inhibitor of Nuclear Export (SINE) Compound, KPT-8602, in Patients with Relapsed Refractory Multiple Myeloma

R. Frank Cornell, MD MS, Adriana C Rossi, MD, MSc, Rachid Baz, MD, Craig C Hofmeister, Chaim Shustik, MD, Joshua R. Richter, MD, Christine Chen, MD, Dan T. Vogl, MD, Sharon Shacham, PhD MBA, Erkan Baloglu, PhD MBA, William Senapedis, PhD, Joel Ellis, PhD, Sharon Friedlander, PhD, Cassandra Choe-Juliak, MD, Christopher L Cubitt, PhD, Joel G Turner, PhD, Daniel Sullivan, MD MS, Michael Kauffman, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4509.
https://doi.org/10.1182/blood.V128.22.4509.4509
Published: 2016
Journal Articles

Cerebrospinal Fluid (CSF) Involvement By Plasma Cell Dyscrasias – Single Center Experience

Taiga Nishihori, MD, Jun Zhou, MD, Kenneth H. Shain, MD PhD, Rachid Baz, MD, Melissa Alsina, MD, Daniel Sullivan, MD MS, Ryan Hillgruber, Elizabeth M. Sagatys, MD, Lynn C. Moscinski, MD, Ling Zhang, MD
Journal: Blood
Blood (2014) 124 (21): 5686.
https://doi.org/10.1182/blood.V124.21.5686.5686
Published: 2014
Journal Articles

A Phase 2 Study of High-Dose Melphalan Plus Bortezomib (Mel/Vel) Conditioning Followed By Autologous Hematopoietic Cell Transplantation in Myeloma

Taiga Nishihori, MD, Jose L Ochoa-Bayona, MD, Rachid Baz, MD, Kenneth H. Shain, MD PhD, Christine Simonelli, RN, Chiaka Nwoga, MPH, CCRP, Ryan Hillgruber, Daniel Sullivan, MD MS, Claudio Anasetti, MD, Melissa Alsina, MD
Journal: Blood
Blood (2014) 124 (21): 3987.
https://doi.org/10.1182/blood.V124.21.3987.3987
Published: 2014
Journal Articles

Age Is the Strongest Independent Prognostic Factor in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: Moffitt Cancer Center Experience

Costanza Paoletti, Lodovico Balducci, MD, Ivette Boler, RN, Mihaela Popa-McKiver, MD, PhD, Martine Externann, MD, PhD, Jyotishankar Raychaudury, MD, Claudio Anasetti, MD, Hugo F. Fernandez, MD, Daniel Sullivan, MD, MS, William S. Dalton, MD, PhD, Teresa Field, Ernesto Ayala, MD, Mohamed A Kharfan-Dabaja, MD, Lia Perez, MD, Janelle Perkins, William E. Janssen, PhD, John Harris, Michael Schell, Rachna Kapoor, MD, MPH, Melissa Alsina, J. Leonel Ochoa-Bayona
Journal: Blood
Blood (2008) 112 (11): 4435.
https://doi.org/10.1182/blood.V112.11.4435.4435
Published: 2008
Journal Articles

Intrinsic Drug Resistance in Multiple Myeloma to Doxorubicin Is Mediated by Soluble Factors

Daniel Sullivan, MD, MS, Jana L. Dawson, Elizabeth J. Ciaravino, Joel G. Turner, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 5106.
https://doi.org/10.1182/blood.V112.11.5106.5106
Published: 2008
Journal Articles

A Phase 1 Clinical-Pharmacodynamic Study of the Farnesyltransferase Inhibitor Tipifarnib in Combination with the Proteasome Inhibitor Bortezomib in Advanced Acute Leukemias.

Jeffrey E. Lancet, MD, Elliott F. Winton, MD, Robert K. Stuart, MD, Michelle Burton, RN, Christopher Cubitt, PhD, Michelle Blaskovich, John Wright, MD, PhD, Said Sebti, PhD, Daniel Sullivan, MD, MS
Journal: Blood
Blood (2008) 112 (11): 1945.
https://doi.org/10.1182/blood.V112.11.1945.1945
Published: 2008